Grupp, S., Grimley, M., Driscoll, T., Mahadeo, K., Leonard, A., Wang, Y., … Manis, J. (2025). Improved hematopoietic stem cell mobilization for gene therapy using single agent motixafortide in sickle cell disease. In Blood (Vol. 146, pp. 2542–2542). American Society of Hematology. https://doi.org/10.1182/blood-2025-2542

Grupp, Stephan, Michael Grimley, Timothy Driscoll, Kris Mahadeo, Alexis Leonard, Yongping Wang, Helen Phillips, et al. “Improved hematopoietic stem cell mobilization for gene therapy using single agent motixafortide in sickle cell disease.” In Blood, 146:2542–2542. American Society of Hematology, 2025. https://doi.org/10.1182/blood-2025-2542.

Grupp S, Grimley M, Driscoll T, Mahadeo K, Leonard A, Wang Y, et al. Improved hematopoietic stem cell mobilization for gene therapy using single agent motixafortide in sickle cell disease. In: Blood. American Society of Hematology; 2025. p. 2542–2542.

Grupp, Stephan, et al. “Improved hematopoietic stem cell mobilization for gene therapy using single agent motixafortide in sickle cell disease.” Blood, vol. 146, no. Supplement 1, American Society of Hematology, 2025, pp. 2542–2542. Crossref, doi:10.1182/blood-2025-2542.

Grupp S, Grimley M, Driscoll T, Mahadeo K, Leonard A, Wang Y, Phillips H, Justus D, Lehmann L, Esrick E, Kanter J, Nikiforow S, Hsieh M, Tisdale J, Sharma A, Crees Z, Manis J. Improved hematopoietic stem cell mobilization for gene therapy using single agent motixafortide in sickle cell disease. Blood. American Society of Hematology; 2025. p. 2542–2542.